Results 1 to 10 of about 39,956 (217)

Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan [PDF]

open access: yesJournal of Infection in Developing Countries, 2009
Background: Shigellosis is a common cause of morbidity, especially in the very young and old, in developing countries.  The disease is treated with antibiotics.
Erum Khan   +5 more
doaj   +3 more sources

Giant subcutaneous granuloma annulare

open access: yesClinical Dermatology Review, 2021
Subcutaneous granuloma annulare is an uncommon, benign self-limiting cutaneous disease, almost exclusively seen in young children. We report a case of 31-year-old male patient, presented with asymptomatic firm plaques over the left lateral malleoli and ...
M R Harish   +3 more
doaj   +1 more source

The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2011
Infection with Salmonella enterica serovar Typhi (S. Typhi) with reduced susceptibility to fluoroquinolones has been associated with fluoroquinolone treatment failure.
Christopher M Parry   +7 more
doaj   +1 more source

Modi-Red Mud Loaded CoCatalyst Activated Persulfate Degradation of Ofloxacin

open access: yesMagnetochemistry, 2023
As an abundant potentially dangerous waste, red mud (RM) requires a straightforward method of resource management. In this paper, an RM catalyst loaded with cobalt (Co-RM) was prepared by the coprecipitation method for the efficient activation of ...
Qu Wu   +3 more
doaj   +1 more source

Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania. [PDF]

open access: yes, 2013
Kibong'oto National Tuberculosis Hospital (KNTH), Kilimanjaro, Tanzania. Characterize the diagnostic process and interim treatment outcomes from patients treated for multidrug-resistant tuberculosis (MDR-TB) in Tanzania.
Boeree, Martin J   +9 more
core   +5 more sources

Aqueous Humour Ofloxacin Concentration after Topical Instillation in Patients with Dry Eye Disease

open access: yesMedicina, 2022
Background and Objectives: A prospective, randomized clinical trial was conducted to evaluate the concentration of ofloxacin in the aqueous humour (AqH) of patients suffering from dry eye disease (DED) after topical instillation.
Konstantinos Kagkelaris   +6 more
doaj   +1 more source

Simultaneous Extraction of Four Antibiotic Compounds from Soil and Water Matrices

open access: yesSeparations, 2022
The incidence of antibiotic resistance is on the rise and becoming a major health concern. Analyzing the presence of antibiotic compounds in the environment is critical for determining the potential health effects for humans, animals, and ecosystems. For
Alison M. Franklin   +3 more
doaj   +1 more source

Evaluation of the intracellular accumulation of fluoroquinolones in mycobacteria by fluorometric assays

open access: yesInternational Journal of Mycobacteriology, 2020
Background: Fluoroquinolones (FQs) are being used as second-line agents in the treatment of tuberculosis caused by multidrug-resistant strains. Ofloxacin (OFX) is being tried as a part of modified multidrug therapy regimens for leprosy.
Nirmala Deo   +3 more
doaj   +1 more source

Ofloxacin Removal from Aqueous Media by Means of Magnetoactive Electrospun Fibrous Adsorbents

open access: yesNanomaterials, 2022
Functionalized electrospun polymer microfibrous membranes were fabricated by electrospinning and further surface-functionalized with magnetic iron oxide (FexOy) nanoparticles to yield magnetoactive nanocomposite fibrous adsorbents.
Petri Ch. Papaphilippou   +6 more
doaj   +1 more source

Diagnosis and Treatment of Chronic Infectious Processes in Ophthalmology: Real Clinical Practice

open access: yesOftalʹmologiâ, 2020
Long-term conjunctival infections are challenging for the outpatient ophthalmologist. This is due to significant changes in microflora towards resistant gram-negative bacteria.
M. A. Kovalevskaya   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy